Navigation Links
The Outlook for Pharmaceuticals in Western Europe
Date:12/13/2012

NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Outlook for Pharmaceuticals in Western Europe

http://www.reportlinker.com/p0203107/The-Outlook-for-Pharmaceuticals-in-Western-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly in the hospital market. Growth, however, will be tempered somewhat by the effects of the global economic recession in the short term. The leading markets are projected to average a CAGR of 2.1% in US dollar terms up to 2016, to represent a combined pharmaceutical market value of over US$240 billion.

What factors are affecting pharmaceutical market growth?

Demand for pharmaceutical products is set to increase over the coming years, in order to fulfil the health needs of the ageing population. Meanwhile, the trend towards generics is set to continue, with several major patent expiries coming up, and with more governments introducing or expanding generic substitution as a cost-containment measure.

Recent austerity measures, introduced to deal with the impact of the economic recession, have included drug price cuts or discounts in markets such as France, Germany, Greece, Italy and Spain. These price cuts will have an impact across Western Europe, as many other countries use a reference pricing system. These price cuts could limit market growth and there are also fears that lower prices could lead to higher levels of parallel exports.

The hospital market is expected to be the main driver of growth in We
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Outlook for Pharmaceuticals in South East Asia
2. The Outlook for Pharmaceuticals in Latin America
3. E7: The Outlook for Pharmaceuticals to 2012
4. The Outlook for Pharmaceuticals in Central & Eastern Europe
5. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
6. World Diagnostic Imaging Market Outlook and Leading Suppliers Business Strategies and Marketing Tactics
7. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
8. South and Central America Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others
9. PDI, Inc. Announces New Multi-Year Win Valued At up to $150 Million and Provides Outlook for 2012
10. Japan Pharma Review: Outlook to 2017
11. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its previously announced registered offering of common shares in ... Pursuant to the Offering, the Company issued 7,286,432 common ... aggregate gross proceeds of approximately $1.45 billion. On March ... and Exchange Commission a final prospectus supplement to its ...
(Date:3/27/2015)...   Hospira, Inc. (NYSE: HSP ... world,s leading provider of injectable drugs and infusion ... of biosimilarity of its proposed biosimilar, Epoetin Hospira, ... conditionally approved name of RETACRIT™, compared to the ... data were presented at the National Kidney Foundation ...
(Date:3/27/2015)... March 27, 2015  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces the reporting of data from a ... for Injection with the Delcath Hepatic Delivery System ... at the Society of Surgical Oncology (SSO) Annual ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
... Jan. 28, 2011 Drug safety remains front and ... the agency strives to improve the public,s perception of ... improving its reputation among consumers and recognizes that its ... important role in that effort. One issue ...
... Burg Simpson Eldredge Hersh & Jardine, P.C., one of the ... that shareholder, Seth. A. Katz, has been appointed by the ... the Plaintiffs, Steering Committee in the multidistrict litigation against DePuy Orthopaedics, ... Hip System. In August 2010, DePuy Orthopaedics, Inc., ...
Cached Medicine Technology:Navigating the Gray Areas of Post-Marketing Surveillance 2Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc. 2
(Date:3/28/2015)... AZ (PRWEB) March 28, 2015 Coffee could ... also help protect you from gum disease, researchers have found. ... against gum disease. , Coffee contains antioxidants. Antioxidants fight gum ... the question researchers at Boston Univ. Henry M. Goldman School ... in the August 2014 issue of the Journal of Periodontology. ...
(Date:3/28/2015)... 2015 With more than 4,500 ... of osteoporosis, osteoarthritis and musculoskeletal diseases gathered here ... be the first time in the 17-year history ... the hot-button topic is an emerging non-pharmaceutical protocol ... scientific principles of Wolff’s law, osteogenic loading at ...
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... 2015 One in three young athletes ... presented today at the American Orthopaedic Society for Sports ... the long term success of surgery for patients aged ... data from 242 patients who underwent ACL reconstruction between ... MBBS, FRACS, from North Sydney Orthopaedic and Sports Medicine ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the ... the first time, key information for understanding and treating ... newly posted story on the Surviving Mesothelioma website. ... Columbia, the British Columbia Cancer Agency, and PhenoPath lab ... molecular alterations and mutations that can lead to ...
Breaking Medicine News(10 mins):Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... to use fertility treatment to create a "saviour sibling" for ... has issued a licence to a clinic allowing it to ... will be a donor for a very ill baby. ... called diamond blackfan anaemia and her only hope of survival ...
... Stephanie Mullen, a type 1 diabetic has been reported missing ... run out of medication// leaving her gravely ill, police have ... left her home in Uphall, at 2 pm on Monday. ... female friend in Livingston. She is white, 5 ft 2in, ...
... by the defence attorneys of the AIIMS hospital, has sought ... where a boy, suffering from cancer, got inflicted with AIDS ... ,The victim, who was nine years old at the ... for treatment of cancer, supposedly has contracted HIV due to ...
... analyze the risk attitudes and consequences of college drinking ... takers compared to women// who are inclined to use ... drinking in the company of friends, counting the number ... of money spent on drinking. ,Steve Benton, ...
... have tolled up 100,000 hours of time as they collaborated ... bird flu.// Researchers eleven UK universities and research labs have ... could be effective against the H5N1 virus. ,The ... help particle physicists examine the huge amounts of data from ...
... of the child is not being revealed in Grampian. NHS there ... time it took up.// Expectant mothers are not being told about ... not because we are getting it wrong but because of time ... get the sex right. When you aggregate that over a day ...
Cached Medicine News:Health News:A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS 2Health News:Risk Attitudes And Consequences Of College Drinking 2Health News:UK Computer Grid In Bird Flu Fight 2Health News:UK Computer Grid In Bird Flu Fight 3
... Roche Diagnostics Task Targeted Automation ... state-of-the-art automation of pre- and ... decapping, sorting / archiving of ... bar code labeled secondary tubes. ...
... The Roche Diagnostics Task ... a state-of-the-art automation of ... the laboratories: decapping, sorting / ... aliquoting into bar code labeled ...
... Save precious time and gain efficiency ... Lab Automation System (LAS), the high-throughput ... sample-processing capabilities. The Olympus OLA2500 LAS ... designed for medium- to high-volume laboratories. ...
The Freedom EVO series platform offers a choice of flexible, scalable solutions for current and future application needs....
Medicine Products: